Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study
Defactinib、Pembrolizumab 和吉西他滨治疗晚期难治性胰腺癌患者:一项 I 期剂量递增和扩展研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-0308
Wang-Gillam, Andrea; Lim, Kian-Huat; McWilliams, Robert; Suresh, Rama; Lockhart, Albert C; Brown, Amberly; Breden, Marcus; Belle, Jad I; Herndon, John; Bogner, Savannah J; Pedersen, Katrina; Tan, Benjamin; Boice, Nicholas; Acharya, Abhi; Abdiannia, Mina; Gao, Feng; Yoon, Harry H; Zhu, Mojun; Trikalinos, Nikolaos A; Ratner, Lee; Aranha, Olivia; Hawkins, William G; Herzog, Brett H; DeNardo, David G